UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6926
Century Therapeutics
IPSC
$343M
| $35.9K | ﹤0.01% |
14,095
-14,623
| -51% | -$46.2K |
|
|
GTI
6927
DELISTED
Graphjet Technology
GTI
| $35.9K | ﹤0.01% |
122
+121
| +12,100% | +$48.7K |
|
6928
Butterfly Network
BFLY
$2.21B
| $35.8K | ﹤0.01% |
42,588
-108,675
| -72% | -$101K |
|
6929
ProShares Short MidCap400
MYY
$2.92M
| $35.7K | ﹤0.01% |
1,744
-858
| -33% | -$17.6K |
|
6930
Cambria Tail Risk ETF
TAIL
$146M
| $35.6K | ﹤0.01% |
3,072
+3,023
| +6,169% | +$35.7K |
|
6931
Kaltura
KLTR
$259M
| $35.6K | ﹤0.01% |
29,667
-56,861
| -66% | -$68.5K |
|
6932
Alliance Entertainment
AENT
$290M
| $35.6K | ﹤0.01% |
11,882
+11,624
| +4,505% | +$29.6K |
|
6933
SOPHiA GENETICS
SOPH
$561M
| $35.6K | ﹤0.01% |
7,770
-203
| -3% | -$990 |
|
6934
PodcastOne
PODC
$100M
| $35.6K | ﹤0.01% |
+21,169
| New | +$40.4K |
|
6935
Veru
VERU
$37.1M
| $35.6K | ﹤0.01% |
4,228
+3,952
| +1,432% | +$45.7K |
|
6936
Pearson
PSO
$9.97B
| $35.6K | ﹤0.01% |
2,849
-489,834
| -99% | -$6.03M |
|
6937
Invesco Galaxy Bitcoin ETF
BTCO
$432M
| $35.6K | ﹤0.01% |
+595
| New | +$39K |
|
6938
CollPlant Biotechnologies
CLGN
$6.25M
| $35.5K | ﹤0.01% |
7,142
+2,362
| +49% | +$13.1K |
|
6939
Wearable Devices
WLDS
$9.28M
| $35.5K | ﹤0.01% |
+86
| New | +$26.4K |
|
6940
Aptevo Therapeutics
APVO
$5.07M
| $35.5K | ﹤0.01% |
+9
| New | +$134K |
|
6941
First Community Corp
FCCO
$322M
| $35.4K | ﹤0.01% |
2,050
-5,353
| -72% | -$89.2K |
|
6942
FT Vest US Equity Deep Buffer ETF January
DJAN
$479M
| $35.2K | ﹤0.01% |
949
-1,766
| -65% | -$64K |
|
|
EEX
6943
DELISTED
Emerald Holding
EEX
| $35.1K | ﹤0.01% |
6,168
-10,947
| -64% | -$65.8K |
|
|
SBT
6944
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $35K | ﹤0.01% |
6,694
-15,267
| -70% | -$75.2K |
|
6945
Franklin US Mid Cap Multifactor Index ETF
FLQM
$1.6B
| $35K | ﹤0.01% |
+682
| New | +$35.1K |
|
6946
Kiora Pharmaceuticals
KPRX
$11.3M
| $34.9K | ﹤0.01% |
+8,320
| New | +$38.8K |
|
6947
FT Vest US Equity Deep Buffer ETF November
DNOV
$400M
| $34.9K | ﹤0.01% |
843
-3,325
| -80% | -$135K |
|
6948
Xtrackers International Real Estate ETF
HAUZ
$1.06B
| $34.9K | ﹤0.01% |
1,730
-549
| -24% | -$11.6K |
|
6949
Intellicheck
IDN
$76.8M
| $34.8K | ﹤0.01% |
10,187
-11,950
| -54% | -$39K |
|
|
NREF
6950
NexPoint Real Estate Finance
NREF
$332M
| $34.8K | ﹤0.01% |
2,536
-5,468
| -68% | -$73.9K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.